Santa Farma İlaç Partners with Advanco to Boost Production Process Efficiency

With over 80 years of heritage in the pharmaceutical sector, Santa Farma İlaç, which produces high-quality solutions for strengthening human health, continues to make technological partnerships and investments that meet global production standards.

Santa Farma İlaç, one of Turkey's established pharmaceutical companies, is continuing its strategic collaboration with Advanco. Santa Farma İlaç CEO Sami Kiresepi states: "As Santa Farma İlaç, we continue our activities with the objective of becoming a reference company in the healthcare sector by integrating local needs into global markets at world standards. This partnership with Advanco makes our processes more agile, our global scale wider and more controlled, while significantly increasing the value of the services we provide to our customers."

Santa Farma İlaç, which has maintained its collaboration with Advanco, a technology company providing world-class solutions for serialization and traceability in the pharmaceutical sector, since 2015, is enhancing the reliability and efficiency of its production processes with the ARC system provided by Advanco.
With Santa Farma İlaç's transition to a CDMO (Contract Development and Manufacturing Organization) structure, the importance of this collaboration with Advanco has increased further, while also contributing to the company's next-generation production goals. As one of Turkey's leading pharmaceutical manufacturers with 127 products in 10 different therapeutic areas, Santa Farma İlaç contributes to the global healthcare sector while drawing attention with its investments in advanced technology across a wide range of fields.

CEO Sami Kiresepi: Our new vision is 'to be a reference company in healthcare that brings together local needs in world markets with global standards'
"As Santa Farma İlaç, we continue our activities with the objective of becoming a reference company in the healthcare sector by integrating local needs into global markets at world standards. At the same time, in an ever-evolving sector, we always maintain our visionary approach in taking forward-looking steps to ensure sustainable and quality production. As Santa Farma İlaç, ensuring reliability, transparency and full compliance with regulations in pharmaceutical manufacturing has always been a priority for us," said CEO Sami Kiresepi, who also commented on the collaboration conducted with Advanco:

"The collaboration we started with Advanco in 2015 is not merely a technical integration, but also an important strategic partnership in terms of shaping future production standards. Thanks to the advanced traceability solutions provided by Advanco, we are making our production processes more efficient while strengthening our commitment to global standards compliance. This partnership plays a critical role in Santa Farma İlaç's transition to a CDMO structure, and makes our processes more agile and our digital network scope wider and more controlled, while increasing the value of the services we provide to both our local and global customers. I believe this collaboration will strengthen and continue for many years to come and will serve as an example to the sector."